Media veteran transitions to digital healthcare, leading telehealth firm eMed at pivotal moment in GLP-1 weight-loss drug expansion Linda Yaccarino, the former CEO of Elon Musk’s social media platform X (formerly Twitter), has taken on a bold new challenge — this time in the digital healthcare arena. On Tuesday, she was named the new Chief Executive Officer of eMed, a Miami-based telehealth startup that specializes in the distribution of GLP-1 medications such as Wegovy and Ozempic, commonly prescribed for weight loss and chronic health management. The appointment marks a sharp pivot for Yaccarino, whose career has largely been rooted in … Continue reading Linda Yaccarino Appointed CEO of eMed After Departing Elon Musk’s X